Provides LLM-optimized access to FDA data through the OpenFDA API and direct regulatory decision document retrieval, covering all 21 OpenFDA endpoints plus 510(k) summaries, De Novo decisions, and PMA approvals.
Enables agent clients to perform read-only regulatory retrieval through tools for searching the corpus, retrieving source text, tracing citations, listing authorities, and inspecting recent filings. It is designed to keep regulated actions and workspace changes behind human review gates.
Enables AI agents to query and analyze FDA adverse events, drug labels, medical device clearances, and other public health datasets through natural language commands.